Edition:
United Kingdom

Abcam PLC (ABCA.L)

ABCA.L on London Stock Exchange

1,193.00GBp
23 Jan 2018
Change (% chg)

7.00 (+0.59%)
Prev Close
1,186.00
Open
1,192.00
Day's High
1,196.00
Day's Low
1,168.00
Volume
74,824
Avg. Vol
474,055
52-wk High
1,196.00
52-wk Low
790.50

Select another date:

Mon, Jan 22 2018

UK's Abcam signs licensing deal with Roche; shares rise

British biotechnology firm Abcam Plc said on Monday it signed a deal with Roche Holding AG to get rights to a portfolio of the Swiss drugmaker's research products in its life science division.

Abcam signs licensing deal with Roche; shares rise

British biotechnology firm Abcam Plc said on Monday it signed a deal with Roche Holding AG to get rights to a portfolio of the Swiss drugmaker's research products in its life science division.

UK's Abcam signs licensing deal with Roche; shares rise

Jan 22 British biotechnology firm Abcam Plc said on Monday it signed a deal with Roche Holding AG to get rights to a portfolio of the Swiss drugmaker's research products in its life science division.

BRIEF-Abcam Says Entered Into License Agreement With Roche​

* ‍HAS ENTERED INTO A DEFINITIVE LICENSE AGREEMENT WITH ROCHE​

BRIEF-Abcam Says Signed Exclusive License Agreement with Roche

* ‍HAS ENTERED INTO A DEFINITIVE LICENSE AGREEMENT WITH ROCHE​

BRIEF-Abcam Says On Track TO DELIVER 10% FY CONSTANT CURRENCY REVENUE GROWTH

* ABCAM PLC - WE EXPECT TO REPORT REVENUE GROWTH FOR FIRST HALF OF APPROXIMATELY 11 PCT

BRIEF-Abcam's Murray Hennessy to step down from non-executive chairman position

* ‍CHAIRMAN, MURRAY HENNESSY, HAS INFORMED BOARD THAT HE HAS ACCEPTED A CEO ROLE​

BRIEF-Abcam posts FY pretax profit 51.9 mln stg

* TOTAL DIVIDEND 10.18 PENCEPER SHARE Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Select another date: